Refine by
Medical S Ai Articles & Analysis
52 news found
Our latest publication in Cardiovascular Engineering and Technology showcases the feasibility and functionality of our VCAST technology, a patented, AI-based medical system developed for non-invasive, clinical quantitative and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. Using a ...
Featured presentations include development compound gadoquatrane, a novel contrast agent for MRI Further research explores potential of AI and digital advances in medical imaging Bayer announced today that new data from the company’s advanced radiology portfolio will be presented at the 2023 European Congress of Radiology (ECR), ...
ByBayer AG
Closing follows announcement of acquisition on January 18, 2023 Acquisition bolsters Bayer’s position in digital medical imaging Blackford will utilize Bayer’s well established “arm’s length” operating model to preserve the company’s entrepreneurial culture Bayer today ...
ByBayer AG
While medical AI has many potential benefits, there are challenges that have not been tackled yet. One of the major challenges is the limited generalizability of many AI algorithms. Applying a medical AI algorithm that is trained in hospital A may give unexpected results when applied in hospital B. Why does this happen? Certain parameters are different between hospitals. If hospital A has Siemens ...
Acquisition is part of Bayer’s innovation strategy in radiology Blackford Analysis provides cutting-edge radiology AI (artificial intelligence) platform technology Following closing of the acquisition, Blackford Analysis to become part of Bayer’s well established “arm’s length” operating model to ...
ByBayer AG
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck Surgery. ...
Perimeter Medical Imaging AI, Inc. (TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) announced another commercial placement of its flagship Perimeter S-Series OCT system at a second hospital within one of the largest healthcare networks in North Texas, which is part of a major national healthcare system. Perimeter is a medical technology ...
” Earlier this year, VeriSIM was awarded a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to fund the AI-driven development of medications for substance use disorder (SUD). ...
RSIP Vision, an experienced developer of groundbreaking AI technologies for medical imaging, today reveals preliminary results from an ongoing clinical study for the evaluation of the reconstruction of a 3D knee model from 2D X-ray images at Assuta Medical Center in Tel Aviv. This tool is based on novel, patent-pending technology, implementing advanced artificial intelligence (AI) to produce an ...
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) announced the commercial placement of its flagship Perimeter S-Series OCT system at a hospital that is part of a major national healthcare system and one of the largest healthcare networks in North Texas. Perimeter is a medical technology company driven to ...
It follows a year of major achievements for the organisation with Transpara which is now installed in health care facilities both across the US and in over 25 countries worldwide. The success of FDA cleared Transpara AI has been marked by a record number of peer reviewed papers and well over 2,000,000 mammograms being read by this unique system. Transpara's developers, ScreenPoint Medical is ...
The companies all focus on applying Artificial Intelligence (AI) to augment medical imaging with the potential to transform how healthcare is delivered. ...
Joseph Hospital, along with Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”) – a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs – ...
Subtle Medical, a healthcare technology company improving the quality and efficiency of medical imaging, announced they are expanding their partnership with Incepto, a leading platform of artificial intelligence solutions for radiology professionals in Europe, by offering their AI applications, SubtleMR and SubtlePET on ...
” SubtleMR™ is an AI-powered software that improves image quality from upwards of 60% faster scan times. ...
Subtle Medical, a key provider of artificial intelligence (AI) solutions for medical imaging, and Siemens Healthineers, a leading medical technology company, officially announced the integration of Subtle Medical’s SubtleMR™ image-enhancement software into the new reconstruction ...
AI applications for medical imaging can improve prioritization, lesion detection, quantification and productivity Cloud-hosted platform provides access to AI applications that integrate into standard medical imaging workflow Market introduction to start in US and several European countries Strategically complements ...
ByBayer AG
The Transpara AI breast care solution, now being used in over 30 countries worldwide to find breast cancers faster and earlier, has 'remarkable potential' to reduce Radiologists' workload, according to a leading research team in Spain. The team at the renowned University Hospital Reina Sofia in Cordoba, has launched a world first prospective 2D AND 3D study to see how they could help ...
VeriSIM Life (VeriSIM), the leading artificial intelligence (AI)-enabled, unique R&D decisions de-risker for breakthrough drug development, announced today it has been awarded a $312,310 grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to fund AI-driven development of medications for substance use disorder (SUD). VeriSIM and UF Scripps ...
Clairvo Technologies, Inc., a wholly owned subsidiary of Marubeni Corporation, secured the certification from Japan’s Pharmaceuticals and Medical Devices Agency. “I am pleased that VIDA has obtained market authorization in Japan, where lung disease is a major and growing health crisis,” said Yasutaka Nakano, MD, PhD Professor and Chairman, ...